Compare
Progyny, Inc. vs Sotera Health Co vs agilon health, inc. vs Viemed Healthcare, Inc.
| Latest fiscal year | Progyny, Inc. PGNY | Sotera Health Co SHC | agilon health, inc. AGL | Viemed Healthcare, Inc. VMD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.29B | $1.16B | $5.93B | $270.28M |
| Revenue growth (YoY) | +10.4% | +5.7% | -2.1% | +20.5% |
| Gross margin | 23.6% | 55.5% | n/a | 57.5% |
| Operating margin | 6.6% | n/a | -7.8% | 8.5% |
| Net margin | 4.5% | 6.7% | -6.6% | 5.5% |
| Net income | $58.52M | $77.95M | -$391.35M | $14.93M |
| EPS (Diluted) | $0.65 | $0.27 | n/a | $0.37 |
| Operating cash flow | $210.19M | $287.19M | -$105.76M | $51.92M |
| Free cash flow | $191.78M | $149.18M | -$119.00M | $11.93M |
| Cash & equivalents | $112.24M | $344.62M | $173.71M | $13.50M |
| Total assets | $742.43M | $3.26B | $1.27B | $199.15M |
| Total liabilities | $226.39M | $2.66B | $1.14B | $55.63M |
| Shareholders' equity | $516.04M | $606.03M | $126.73M | $141.54M |
| Return on year-end equity | 11.3% | 12.9% | -308.8% | 10.6% |
| Shares outstanding | 83.37M | n/a | 414.73M | 38.02M |
Revenue, most recent five fiscal years
| Fiscal year | Progyny, Inc. | Sotera Health Co | agilon health, inc. | Viemed Healthcare, Inc. |
|---|---|---|---|---|
| Latest | $1.29B Ended 2025-12-31 | $1.16B Ended 2025-12-31 | $5.93B Ended 2025-12-31 | $270.28M Ended 2025-12-31 |
| 1 year earlier | $1.17B Ended 2024-12-31 | $1.10B Ended 2024-12-31 | $6.06B Ended 2024-12-31 | $224.26M Ended 2024-12-31 |
| 2 years earlier | $1.09B Ended 2023-12-31 | $1.05B Ended 2023-12-31 | $4.32B Ended 2023-12-31 | $183.01M Ended 2023-12-31 |
| 3 years earlier | $786.91M Ended 2022-12-31 | $1.00B Ended 2022-12-31 | $2.39B Ended 2022-12-31 | $138.83M Ended 2022-12-31 |
| 4 years earlier | $500.62M Ended 2021-12-31 | $931.48M Ended 2021-12-31 | $1.52B Ended 2021-12-31 | $117.06M Ended 2021-12-31 |